Share Price and Basic Stock Data

Last Updated: November 21, 2024, 9:03 pm

Market Cap	90.1 Cr.
Current Price	43.9
High / Low	63.6/35.1
Stock P/E	125
Book Value	32.2
Dividend Yield	0.00 %
ROCE	3.69 %
ROE	0.75 %
Face Value	10.0
PEG Ratio	-7.38

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Archit Organosys Ltd

Competitors of Archit Organosys Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Gujchem Distillers India Ltd	108 Cr.	304	541/61.8	285	390	0.00 %	1.38 %	2.17 %	1.00
Elantas Beck India Ltd	10,175 Cr.	12,831	14,980/6,445	69.3	1,018	0.04 %	27.7 %	20.6 %	10.0
Crestchem Ltd	87.3 Cr.	291	350/70.0	27.6	21.1	0.17 %	78.2 %	56.2 %	10.0
Chemiesynth (Vapi) Ltd	11.0 Cr.	35.8	34.1/0.00		37.5	0.00 %	1.00 %	3.38 %	10.0
Archit Organosys Ltd	90.1 Cr.	43.9	63.6/35.1	125	32.2	0.00 %	3.69 %	0.75 %	10.0
Industry Average	6,949.00 Cr	1,987.93		73.49	312.95	0.27%	16.32%	12.33%	7.67

All Competitor Stocks of Archit Organosys Ltd

Quarterly Result

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	28.67	42.96	38.74	26.29	30.35	28.46	22.42	46.55	31.00	26.39	24.81	30.99	27.00
Expenses	24.08	38.46	35.62	21.85	23.18	23.23	18.83	43.63	27.76	24.28	23.71	30.70	23.95
Operating Profit	4.59	4.50	3.12	4.44	7.17	5.23	3.59	2.92	3.24	2.11	1.10	0.29	3.05
OPM %	16.01%	10.47%	8.05%	16.89%	23.62%	18.38%	16.01%	6.27%	10.45%	8.00%	4.43%	0.94%	11.30%
Other Income	0.04	0.16	1.30	0.42	0.21	0.17	1.84	1.35	0.71	0.54	0.52	4.11	0.47
Interest	0.58	0.55	0.65	0.67	0.86	0.32	0.52	0.50	0.52	0.65	0.77	0.64	0.62
Depreciation	1.14	1.17	1.14	1.23	1.20	1.17	1.31	1.17	1.19	1.49	1.49	1.48	1.49
Profit before tax	2.91	2.94	2.63	2.96	5.32	3.91	3.60	2.60	2.24	0.51	-0.64	2.28	1.41
Tax %	-0.34%	52.04%	22.81%	36.49%	22.56%	21.74%	37.78%	22.69%	26.79%	27.45%	-29.69%	21.49%	29.08%
Net Profit	2.92	1.41	2.03	1.87	4.12	3.06	2.24	2.01	1.64	0.37	-0.46	1.79	1.01
EPS in Rs	1.42	0.69	0.99	0.91	2.01	1.49	1.09	0.98	0.80	0.18	-0.22	0.87	0.49

Last Updated: October 7, 2024, 8:38 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	38	49	56	51	48	82	84	77	95	138	128	113	109
Expenses	37	47	53	48	44	78	87	73	83	121	108	106	103
Operating Profit	1	2	2	3	4	4	-3	4	11	17	20	7	7
OPM %	4%	5%	4%	6%	8%	5%	-4%	5%	12%	12%	15%	6%	6%
Other Income	1	-0	1	1	0	3	3	2	0	1	3	6	6
Interest	1	1	1	1	1	4	4	3	3	2	2	3	3
Depreciation	0	0	0	0	1	3	3	3	4	5	5	6	6
Profit before tax	1	1	1	2	3	0	-6	-1	5	11	15	4	4
Tax %	24%	33%	43%	37%	42%	-32%	-25%	1%	-7%	28%	26%	24%
Net Profit	1	1	1	1	2	1	-5	-1	5	8	11	3	3
EPS in Rs	0.55	0.65	0.87	0.97	1.14	0.34	-3.14	-0.53	3.34	4.01	5.57	1.63	1.32
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	15%	19%	9%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	0.00%	0.00%	0.00%	100.00%	-50.00%	-600.00%	80.00%	600.00%	60.00%	37.50%	-72.73%
Change in YoY Net Profit Growth (%)	0.00%	0.00%	0.00%	100.00%	-150.00%	-550.00%	680.00%	520.00%	-540.00%	-22.50%	-110.23%

Archit Organosys Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	6%
3 Years:	6%
TTM:	-11%

Compounded Profit Growth
10 Years:	-7%
5 Years:	16%
3 Years:	-55%
TTM:	-86%

Stock Price CAGR
10 Years:	17%
5 Years:	36%
3 Years:	1%
1 Year:	-12%

Return on Equity
10 Years:	7%
5 Years:	10%
3 Years:	11%
Last Year:	1%

Last Updated: Unknown

Balance Sheet

Last Updated: September 15, 2024, 2:12 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	3	3	3	5	10	15	15	15	15	21	21	21
Reserves	1	2	2	8	17	25	20	19	24	31	41	44
Borrowings	7	7	9	11	31	36	37	33	30	34	31	26
Other Liabilities	5	9	10	8	12	26	12	16	18	18	27	18
Total Liabilities	16	21	24	32	70	101	84	83	87	104	120	108
Fixed Assets	5	5	6	6	47	47	47	50	48	45	50	60
CWIP	0	0	0	8	1	8	5	1	3	13	14	1
Investments	0	0	0	0	0	0	0	0	0	1	4	6
Other Assets	11	16	18	18	22	46	32	32	37	44	52	42
Total Assets	16	21	24	32	70	101	84	83	87	104	120	108

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	2	1	2	1	2	-4	3	8	11	11	18	10
Cash from Investing Activity +	-0	-0	-2	-8	-35	-9	1	-1	-3	-12	-12	-2
Cash from Financing Activity +	-4	-0	1	7	32	13	0	-9	-7	2	-7	-9
Net Cash Flow	-2	0	0	-0	-0	0	4	-2	1	2	-0	-1

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-6.00	-5.00	-7.00	-8.00	-27.00	-32.00	-40.00	-29.00	-19.00	-17.00	-11.00	-19.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	84	101	76	79	86	140	62	94	97	72	107	72
Inventory Days	17	10	28	28	27	41	30	22	21	22	16	16
Days Payable	58	80	72	63	80	126	55	88	87	51	101	63
Cash Conversion Cycle	44	31	33	44	33	56	38	28	30	44	22	25
Working Capital Days	62	51	47	58	54	49	36	29	56	54	59	68
ROCE %	15%	19%	20%	17%	9%	6%	-4%	3%	12%	18%	17%	4%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	57.40%	57.40%	57.40%	59.83%	61.64%	62.37%	62.37%	62.37%	62.37%	63.26%	64.65%	64.65%
Public	42.60%	42.60%	42.60%	40.17%	38.36%	37.63%	37.63%	37.63%	37.62%	36.74%	35.35%	35.35%
No. of Shareholders	7,647	7,702	8,407	9,108	9,608	9,668	9,748	11,597	11,409	11,298	10,596	10,389

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	1.63	5.57	4.01	3.33	-0.53
Diluted EPS (Rs.)	1.63	5.57	4.24	3.33	-0.53
Cash EPS (Rs.)	4.38	7.92	6.29	5.77	1.78
Book Value[Excl.RevalReserv]/Share (Rs.)	31.26	30.14	25.29	26.99	22.71
Book Value[Incl.RevalReserv]/Share (Rs.)	31.26	30.14	25.29	26.99	22.71
Dividend / Share (Rs.)	0.00	0.50	0.75	0.50	0.00
Revenue From Operations / Share (Rs.)	55.16	62.27	66.60	62.92	51.06
PBDIT / Share (Rs.)	4.51	10.15	9.04	7.72	3.88
PBIT / Share (Rs.)	1.75	7.79	6.76	5.28	1.57
PBT / Share (Rs.)	2.14	7.52	5.57	3.12	-0.52
Net Profit / Share (Rs.)	1.63	5.57	4.01	3.33	-0.53
PBDIT Margin (%)	8.17	16.29	13.57	12.26	7.61
PBIT Margin (%)	3.17	12.51	10.14	8.38	3.07
PBT Margin (%)	3.87	12.07	8.36	4.95	-1.03
Net Profit Margin (%)	2.94	8.94	6.02	5.29	-1.04
Return on Networth / Equity (%)	5.20	18.47	15.86	12.35	-2.34
Return on Capital Employeed (%)	4.85	20.41	21.02	14.90	4.96
Return On Assets (%)	3.08	9.33	7.94	5.72	-0.96
Long Term Debt / Equity (X)	0.11	0.22	0.23	0.29	0.36
Total Debt / Equity (X)	0.40	0.50	0.61	0.53	0.78
Asset Turnover Ratio (%)	0.98	1.13	1.43	1.11	0.91
Current Ratio (X)	1.21	1.20	1.14	0.99	0.85
Quick Ratio (X)	1.11	1.13	0.98	0.89	0.75
Inventory Turnover Ratio (X)	10.10	8.42	11.41	8.98	6.09
Dividend Payout Ratio (NP) (%)	30.73	13.46	12.46	0.00	0.00
Dividend Payout Ratio (CP) (%)	11.40	9.46	7.94	0.00	0.00
Earning Retention Ratio (%)	69.27	86.54	87.54	0.00	0.00
Cash Earning Retention Ratio (%)	88.60	90.54	92.06	0.00	0.00
Interest Coverage Ratio (X)	3.59	9.43	7.60	3.57	1.85
Interest Coverage Ratio (Post Tax) (X)	0.98	5.43	4.37	2.54	0.74
Enterprise Value (Cr.)	110.21	149.75	106.90	55.06	32.47
EV / Net Operating Revenue (X)	0.97	1.17	0.78	0.58	0.42
EV / EBITDA (X)	11.91	7.19	5.76	4.75	5.56
MarketCap / Net Operating Revenue (X)	0.78	0.96	0.58	0.39	0.11
Retention Ratios (%)	69.26	86.53	87.53	0.00	0.00
Price / BV (X)	1.38	2.00	1.54	0.91	0.25
Price / Net Operating Revenue (X)	0.78	0.96	0.58	0.39	0.11
EarningsYield	0.03	0.09	0.10	0.13	-0.09

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Archit Organosys Ltd as of November 21, 2024 is: 30.79

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 21, 2024, Archit Organosys Ltd is Overvalued by 29.86% compared to the current share price 43.90

Intrinsic Value of Archit Organosys Ltd as of November 21, 2024 is: 25.57

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 21, 2024, Archit Organosys Ltd is Overvalued by 41.75% compared to the current share price 43.90

Last 5 Year EPS CAGR: -16.95%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has shown consistent growth in sales (82.15 cr) and profit (3.08 cr) over the years.	The stock has a low average ROCE of 11.33%, which may not be favorable. The stock has a high average Working Capital Days of 51.92, which may not be favorable. The stock has a high average Cash Conversion Cycle of 35.67, which may not be favorable. The company has higher borrowings (24.33) compared to reserves (19.50), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Archit Organosys Ltd:
1. Net Profit Margin: 2.94%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.85% (Industry Average ROCE: 16.32%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 5.2% (Industry Average ROE: 12.33%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 0.98
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.11
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 125 (Industry average Stock P/E: 63.69)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.4
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Archit Organosys Ltd. is a Public Limited Listed company incorporated on 04/08/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1993PLC019941 and registration number is 019941. Currently company belongs to the Industry of Chemicals - Organic - Others. Company’s Total Operating Revenue is Rs. 136.66 Cr. and Equity Capital is Rs. 20.52 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Others	9th Floor, Venus Benecia, Ahmedabad Gujarat 380054	share@architorg.com http://www.architorg.com

Management
Name	Position Held
Mr. Kandarp Amin	Chairman & Wholetime Director
Mr. Archit Amin	Whole Time Director
Mrs. Archana Amin	Whole Time Director
Mr. Nikul Patel	Independent Director
Mr. Shreeraj Desai	Independent Director
Mr. Bhavin Shah	Independent Director
Mr. Vatsal Vora	Independent Director

FAQ

What is the latest intrinsic value of Archit Organosys Ltd?

The latest intrinsic value of Archit Organosys Ltd as on 21 November 2024 is ₹30.79, which is 29.86% lower than the current market price of ₹43.90.

What is the Market Cap of Archit Organosys Ltd?

The Market Cap of Archit Organosys Ltd is 90.1 Cr..

What is the current Stock Price of Archit Organosys Ltd as on 21 November 2024?

The current stock price of Archit Organosys Ltd as on 21 November 2024 is ₹43.9.

What is the High / Low of Archit Organosys Ltd stocks in FY 2024?

In FY 2024, the High / Low of Archit Organosys Ltd stocks is 63.6/35.1.

What is the Stock P/E of Archit Organosys Ltd?

The Stock P/E of Archit Organosys Ltd is 125.

What is the Book Value of Archit Organosys Ltd?

The Book Value of Archit Organosys Ltd is 32.2.

What is the Dividend Yield of Archit Organosys Ltd?

The Dividend Yield of Archit Organosys Ltd is 0.00 %.

What is the ROCE of Archit Organosys Ltd?

The ROCE of Archit Organosys Ltd is 3.69 %.

What is the ROE of Archit Organosys Ltd?

The ROE of Archit Organosys Ltd is 0.75 %.

What is the Face Value of Archit Organosys Ltd?

The Face Value of Archit Organosys Ltd is 10.0.